Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zepbound
Pharma
Lilly: Zepbound, Mounjaro supply to remain tight through 2024
While Lilly's incretin supply should increase during the second half of the year, demand is still expected to outpace supply at least through 2024.
Zoey Becker
Apr 30, 2024 12:03pm
Lilly to beef up injectables production with Nexus plant in WI
Apr 23, 2024 3:07pm
Eli Lilly's Mounjaro, Zepbound supply outlook worsens
Apr 18, 2024 10:22am
Eli Lilly's tirzepatide excels in phase 3 sleep apnea studies
Apr 17, 2024 11:04am
Lilly's Mounjaro will be in short supply through April, FDA says
Apr 2, 2024 5:12pm
Demand for Lilly's Zepbound triggers US supply constraints
Mar 29, 2024 1:14pm